Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,873) with videos related to
Page
of 188
Sort By:
European Journal of Heart Failure
|
November 17, 2017
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial
Muthiah Vaduganathan, Baljash Cheema, Erin Cleveland, et al.
Circulation. Heart Failure
|
December 16, 2017
Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance
Tonje Thorvaldsen, Brian L Claggett, Amil Shah, et al.
JACC. Cardiovascular Imaging
|
April 10, 2009
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
Anil Verma, Alessandra Meris, Hicham Skali, et al.
JAMA Cardiology
|
March 4, 2026
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study
Mats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
European Heart Journal
|
April 4, 2017
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
Burkert Pieske, Aldo P Maggioni, Carolyn S P Lam, et al.
European Heart Journal. Cardiovascular Imaging
|
July 3, 2024
Cardiac mechanics and the risk of atrial fibrillation in a community-based cohort of older adults
Riccardo M Inciardi, Wendy Wang, Alvaro Alonso, et al.
European Journal of Heart Failure
|
October 30, 2015
The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics
Henry Krum, John J V McMurray, William T Abraham, et al.
European Journal of Heart Failure
|
July 27, 2022
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trial
Safia Chatur, Muthiah Vaduganathan, Alexander Peikert, et al.
European Journal of Heart Failure
|
July 17, 2019
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics
John J V McMurray, David L DeMets, Silvio E Inzucchi, et al.
Journal of the American Heart Association
|
April 25, 2016
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Marwa A Sabe, Brian Claggett, Emmanuel A Burdmann, et al.
Page
of 188
Search research articles
Search
Showing results (1061-1070 of 1,873) with videos related to
Sort By:
Page
of 188
European Journal of Heart Failure
|
November 17, 2017
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial
Muthiah Vaduganathan, Baljash Cheema, Erin Cleveland, et al.
Circulation. Heart Failure
|
December 16, 2017
Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance
Tonje Thorvaldsen, Brian L Claggett, Amil Shah, et al.
JACC. Cardiovascular Imaging
|
April 10, 2009
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
Anil Verma, Alessandra Meris, Hicham Skali, et al.
JAMA Cardiology
|
March 4, 2026
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study
Mats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
European Heart Journal
|
April 4, 2017
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
Burkert Pieske, Aldo P Maggioni, Carolyn S P Lam, et al.
European Heart Journal. Cardiovascular Imaging
|
July 3, 2024
Cardiac mechanics and the risk of atrial fibrillation in a community-based cohort of older adults
Riccardo M Inciardi, Wendy Wang, Alvaro Alonso, et al.
European Journal of Heart Failure
|
October 30, 2015
The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics
Henry Krum, John J V McMurray, William T Abraham, et al.
European Journal of Heart Failure
|
July 27, 2022
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trial
Safia Chatur, Muthiah Vaduganathan, Alexander Peikert, et al.
European Journal of Heart Failure
|
July 17, 2019
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics
John J V McMurray, David L DeMets, Silvio E Inzucchi, et al.
Journal of the American Heart Association
|
April 25, 2016
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Marwa A Sabe, Brian Claggett, Emmanuel A Burdmann, et al.
Page
of 188